Microbiome Technology Equipment
-
based in FRANCE
Eligobiotics are a first-in-class proprietary modality that enables the delivery and expression of therapeutic DNA in target bacterial populations of the microbiome. This technology allows modulation of the microbiome’s composition and function to address human disease with an unprecedented ...
-
Manufactured by OptiBiotix Health Plc.based in UNITED KINGDOM
The human digestive tract contains a complex and diverse ecosystem of trillions of microorganisms, mainly bacteria. Recent advances in molecular and analytical techniques have permitted identification of bacterial species and strains that inhabit the gastrointestinal tract, their metabolic activity, and interactions with the human host. These studies have provided greater insight into the role ...
-
Manufactured by Bio-Mebased in NORWAY
A high-throughput microbiome analysis platform that holds features required for routine clinical applications. Bio-Me’s Precision Microbiome Profiling (PMP™) technology is enabling rapid access to precise gut microbiome data, empowering researchers to undertake efficient and actionable microbiome ...
-
Manufactured by MedBiome Inc.based in CANADA
The RapidAIM technology allows the rapid screening of compounds against individual human microbiomes and greatly accelerates the discovery of compounds that target the human microbiomes. Our current technology can also be used to de-risk compounds, stratify patients based on their microbiome responses and other ...
-
Manufactured by Moon (Guangzhou) Biotech Co.,Ltdbased in CHINA
of innovative microbiome-driven therapeutics. Our proprietary Moon Culture-To-Product® Microbiome Technology Platform empower us to systematically, precisely and rapidly discover full spectrum microbe-based drugs via the established bioinformatics, microbial, genetics and metabolites resources. ...
-
Manufactured by Locus Biosciences, Inc.based in USA
Locus has built the most innovative tool to reach into the human body and deliver a therapeutic manufactured by the ...
-
based in AUSTRALIA
Developing novel therapeutics from the human microbiome; The uncultured portion of the human gut microbiome, which is the majority of microbial species, represents untapped therapeutic opportunity. Microba has established a platform for drug discovery and development that leverages a growing, proprietary Databank of human microbiome ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you